Search Results - "Litzenberg, Kevin T."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    NNMT Silencing Activates Tumor Suppressor PP2A, Inactivates Oncogenic STKs, and Inhibits Tumor Forming Ability by Palanichamy, Kamalakannan, Kanji, Suman, Gordon, Nicolaus, Thirumoorthy, Krishnan, Jacob, John R, Litzenberg, Kevin T, Patel, Disha, Chakravarti, Arnab

    Published in Clinical cancer research (01-05-2017)
    “…To identify potential molecular hubs that regulate oncogenic kinases and target them to improve treatment outcomes for glioblastoma patients. Data mining of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Cancer Is an Independent Risk Factor for Acute Respiratory Distress Syndrome in Critically Ill Patients: A Single Center Retrospective Cohort Study by Ho, Kevin, Gordon, Joshua, Litzenberg, Kevin T., Exline, Matthew C., Englert, Joshua A., Herman, Derrick D.

    Published in Journal of intensive care medicine (01-03-2022)
    “…Background: Acute Respiratory Distress Syndrome (ARDS) is a frequent cause of respiratory failure in intensive care unit (ICU) patients and results in…”
    Get full text
    Journal Article
  4. 4

    Lack of Constitutively Active DNA Repair Sensitizes Glioblastomas to Akt Inhibition and Induces Synthetic Lethality with Radiation Treatment in a p53-Dependent Manner by Palanichamy, Kamalakannan, Patel, Disha, Jacob, John R, Litzenberg, Kevin T, Gordon, Nicolaus, Acus, Kirstin, Noda, Shin-Ei, Chakravarti, Arnab

    Published in Molecular cancer therapeutics (01-02-2018)
    “…Treatment refractory glioblastoma (GBM) remains a major clinical problem globally, and targeted therapies in GBM have not been promising to date. The Cancer…”
    Get full text
    Journal Article
  5. 5

    Cells isolated from residual intracranial tumors after treatment express iPSC genes and possess neural lineage differentiation plasticity by Palanichamy, Kamalakannan, Jacob, John R., Litzenberg, Kevin T., Ray-Chaudhury, Abhik, Chakravarti, Arnab

    Published in EBioMedicine (01-10-2018)
    “…The goal of this study is to identify and characterize treatment resistant tumor initiating cells (TRTICs) using orthotopic xenografts. TRTICs were enriched…”
    Get full text
    Journal Article
  6. 6

    Cells isolated from residual intracranial tumors after treatment express iPSC genes and possess neural lineage differentiation plasticityResearch in context by Kamalakannan Palanichamy, John R. Jacob, Kevin T. Litzenberg, Abhik Ray-Chaudhury, Arnab Chakravarti

    Published in EBioMedicine (01-10-2018)
    “…Background: The goal of this study is to identify and characterize treatment resistant tumor initiating cells (TRTICs) using orthotopic xenografts. Methods:…”
    Get full text
    Journal Article